| 利用者成果(英) |
|
22524
Kasai F, Fukushima M, Miyagi Y, Nakamura Y.
Genetic diversity among the present Japanese population: evidence from genotyping of human cell lines established in Japan
Hum Cell
2024
37(4):944-950
PubMed ID: 38639832
DOI: 10.1007/s13577-024-01055-0
|
|
13332
Hase H, Aoki M, Matsumoto K, Nakai S, Nagata T, Takeda A, Ueda K, Minami K, Kitae K, Jingushi K, Ueda Y, Yamamoto M, Furukawa T, Sato M, Tsujikawa K.
Cancer type‑SLCO1B3 promotes epithelial‑mesenchymal transition resulting in the tumour progression of non‑small cell lung cancer.
Oncol Rep
2021
PubMed ID: 33155667
DOI: 10.3892/or.2020.7839
|
|
11379
Omoto K, Matsuda R, Nakai Y, Tatsumi Y, Nakazawa T, Tanaka Y, Shida Y, Murakami T, Nishimura F, Nakagawa I, Motoyama Y, Nakamura M, Fujimoto K, Hiroyuki N.
Expression of peptide transporter 1 has a positive correlation in protoporphyrin IX accumulation induced by 5-aminolevulinic acid with photodynamic detection of non-small cell lung cancer and metastatic brain tumor specimens originating from non-small cell lung cancer.
Photodiagnosis Photodyn Ther
2019
PubMed ID: 30639584
DOI: 10.1016/j.pdpdt.2019.01.009
|
|
10585
Homma S, Hayashi K, Yoshida K, Sagawa Y, Kamata Y, Ito M.
Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells.
Int. Immunopharmacol.
2018
54:39-45
PubMed ID: 29100036
DOI: 10.1016/j.intimp.2017.10.016
|
|
4231
Yamaura T, Ezaki J, Okabe N, Takagi H, Ozaki Y, Inoue T, Watanabe Y, Fukuhara M, Muto S, Matsumura Y, Hasegawa T, Hoshino M, Osugi J, Shio Y, Waguri S, Tamura H, Imai JI, Ito E, Yanagisawa Y, Honma R, Watanabe S, Suzuki H.
Family with sequence similarity 83, member B is a predictor of poor prognosis and a potential therapeutic target for lung adenocarcinoma expressing wild-type epidermal growth factor receptor.
Oncol Lett
2018
PubMed ID: 29434849
DOI: 10.3892/ol.2017.7517
|
|
10378
Tsubouchi H, Onomura H, Saito Y, Yanagi S, Miura A, Matsuo A, Matsumoto N, Nakazato M.
Ghrelin does not influence cancer progression in a lung adenocarcinoma cell line.
Endocr. J.
2017
64:S41-S46
PubMed ID: 28652543
DOI: 10.1507/endocrj.64.S41
|
|
19389
Ohue Y, Kurose K, Nozawa R, Isobe M, Nishio Y, Tanaka T, Doki Y, Hori T, Fukuoka J, Oka M, Nakayama E.
Survival of Lung Adenocarcinoma Patients Predicted from Expression of PD-L1, Galectin-9, and XAGE1 (GAGED2a) on Tumor Cells and Tumor-Infiltrating T Cells
Cancer Immunol Res
2016
4(12):1049-1060
PubMed ID: 27799141
DOI: 10.1158/2326-6066.CIR-15-0266
|
|
17162
Kimura M, Naito H, Tojo T, Itaya-Hironaka A, Dohi Y, Yoshimura M, Nakagawara K, Takasawa S, Taniguchi S.
REG Iα gene expression is linked with the poor prognosis of lung adenocarcinoma and squamous cell carcinoma patients via discrete mechanisms
Oncol Rep
2013
30(6):2625-31
PubMed ID: 24065141
DOI: 10.3892/or.2013.2739
|
|
5867
Tsuboi M, Mori H, Bunai T, Kageyama S, Suzuki M, Okudela K, Takamochi K, Ogawa H, Niwa H, Shinmura K, Sugimura H.
Secreted form of EphA7 in lung cancer.
Int J Oncol
2010
36(3):635-40
PubMed ID: 20126984
|
|
6410
Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.
Is parainfluenza virus a threatening virus for human cancer cell lines?
Hum Cell
2009
22(3):81-4
PubMed ID: 19624309
DOI: 10.1111/j.1749-0774.2009.00071.x
|
|
17469
Takiguchi Y, Miyamoto T, Nagao K, Kuriyama T.
Assessment of the homogeneous efficacy of carbon ions in the spread-out Bragg peak for human lung cancer cell lines
Radiat Med
2007
25(6):272-7
PubMed ID: 17634880
DOI: 10.1007/s11604-007-0134-6
|
|
13698
Matsubara D, Niki T, Ishikawa S, Goto A, Ohara E, Yokomizo T, Heizmann CW, Aburatani H, Moriyama S, Moriyama H, Nishimura Y, Funata N, Fukayama M.
Differential expression of S100A2 and S100A4 in lung adenocarcinomas: clinicopathological significance, relationship to p53 and identification of their target genes
Cancer Sci
2005
96(12):844-57
PubMed ID: 16367903
DOI: 10.1111/j.1349-7006.2005.00121.x
|
|
16491
Nakanishi H, Suda T, Katoh M, Watanabe A, Igishi T, Kodani M, Matsumoto S, Nakamoto M, Shigeoka Y, Okabe T, Oshimura M, Shimizu E.
Loss of imprinting of PEG1/MEST in lung cancer cell lines
Oncol Rep
2004
12(6):1273-8
PubMed ID: 15547750
|
|
13743
Niki T, Kohno T, Iba S, Moriya Y, Takahashi Y, Saito M, Maeshima A, Yamada T, Matsuno Y, Fukayama M, Yokota J, Hirohashi S.
Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas
Am J Pathol
2002
160(3):1129-41
PubMed ID: 11891209
DOI: 10.1016/s0002-9440(10)64933-4
|
|
2483
Niki T, Iba S, Tokunou M, Yamada T, Matsuno Y, Hirohashi S
Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma.
Clin Cancer Res
2000
6:2431-9
PubMed ID: 10873096
|
|
18751
Sasaki Y, Takahashi T, Miyazaki H, Matsumoto A, Kato T, Nakamura K, Iho S, Okuno Y, Nakao K.
Production of thrombopoietin by human carcinomas and its novel isoforms
Blood
1999
94(6):1952-60
PubMed ID: 10477724
|
|
17903
Oshima M, Sugiyama H, Kitagawa K, Taketo M.
APC gene messenger RNA: novel isoforms that lack exon 7
Cancer Res
1993
53(23):5589-91
PubMed ID: 8242607
|
戻る
細胞材料の再培養方法 (
HPS以外・
HPS )
ページトップへ
細胞材料開発室サイト
